Mostrar el registro sencillo del ítem

Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023

dc.contributor.authorMartinón Torres, Federico *
dc.contributor.authorMirás Carballal, Susana*
dc.contributor.authorDurán Parrondo, Carmen *
dc.date.accessioned2025-09-09T10:22:59Z
dc.date.available2025-09-09T10:22:59Z
dc.date.issued2023
dc.identifier.citationMartinón-Torres F, Mirás-Carballal S, Durán-Parrondo C. Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2023;28(49).
dc.identifier.issn1560-7917
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/65911dbeae63c86e421b9c6c
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21377
dc.description.abstractA monoclonal antibody for universal respiratory syncytial virus prophylaxis in infants has recently been licensed. We share our experiences of integrating nirsevimab into the regional immunisation programme in Galicia, Spain. After a 3-week hospital-based immunisation campaign with flexible individualised appointments and educational activities, nirsevimab uptake was 97.5% in the high-risk group, 81.4% in the catch-up group and 92.6% in infants born during the campaign. This successful implementation strategy can serve as a model and may inform other countries' programmatic deliberations.
dc.description.sponsorshipThis work was supported by Framework Partnership Agreement between the Conselleria de Sanidad de la XUNTA de Galicia and GENVIP-IDIS-2021-2024 (SERGAS-IDIS March 2021; Spain) ; and consorcio Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CB21/06/00103; F.M-T) , DIAVIR (Instituto de Salud Carlos III (ISCIII)/DTS19/00049/Cofinanciado FEDER; Proyecto de Desarrollo Tecnologico en Salud) , Resvi-Omics (Instituto de Salud Carlos III (ISCIII) /PI19/01039/Cofinanciado FEDER) , BI-BACVIR (PRIS-3; Agencia de Conocimiento en Salud (ACIS)-Servicio Gallego de Salud (SERGAS)-Xunta de Galicia; Spain) , Programa Traslacional COVID-19 (ACIS- Servicio Gallego de Salud (SERGAS)-XUNTA de Galicia; Spain) and Axencia Galega de Innovacion (GAIN; IN607B 2020/08-XUNTA de Galicia; Spain) ; and ReSVinext (Instituto de Salud Carlos III (ISCIII)/PI16/01569/Cofinanciado FEDER) , Enterogen (Instituto de Salud Carlos III (ISCIII)/PI19/01090/Cofinanciado FEDER) , OMI-COVI-VAC (PI22/00406/Cofinanced European Regional Development Fund, Grupos de Referencia Competitiva (IIN607A2021/05) and Axencia Galega de Innovacion (GAIN; IN845D 2020/23-Xunta de Galicia; Spain) ; and NIRSE-GAL Project grant 2023 from Sanofi Pasteur to Healthcare Research Institute of Santiago de Compostela [F.M-T] .
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshInfant *
dc.subject.meshHumans *
dc.subject.meshAntibodies, Monoclonal *
dc.subject.meshPalivizumab *
dc.subject.meshRespiratory Syncytial Virus Infections *
dc.subject.meshSpain *
dc.subject.meshRespiratory Syncytial Viruses *
dc.subject.meshAntiviral Agents *
dc.subject.meshRespiratory Syncytial Virus, Human*
dc.titleEarly lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023
dc.typeArtigo
dc.authorsophosMartinón-Torres, F.; Mirás-Carballal, S.; Durán-Parrondo, C.
dc.identifier.doi10.2807/1560-7917.es.2023.28.49.2300606
dc.identifier.sophos65911dbeae63c86e421b9c6c
dc.issue.number49
dc.journal.titleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Pediatría
dc.organizationDirección Xeral de Saúde Pública
dc.organizationDirección Xeral de Saúde Pública
dc.relation.projectIDConselleria de Sanidad de la XUNTA de Galicia
dc.relation.projectIDGENVIP-IDIS-2021-2024 (SERGAS-IDIS March 2021
dc.relation.projectIDSpain)
dc.relation.projectIDConsorcio Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias [CB21/06/00103]
dc.relation.projectIDDIAVIR (Instituto de Salud Carlos III (ISCIII)/FEDER) [DTS19/00049]
dc.relation.projectIDResvi-Omics (Instituto de Salud Carlos III (ISCIII)/FEDER) [PI19/01039]
dc.relation.projectIDBI-BACVIR (PRIS-3
dc.relation.projectIDAgencia de Conocimiento en Salud (ACIS)-Servicio Gallego de Salud (SERGAS)-Xunta de Galicia
dc.relation.projectIDSpain)
dc.relation.projectIDReSVinext (Instituto de Salud Carlos III (ISCIII)/FEDER) [PI16/01569]
dc.relation.projectIDEnterogen (Instituto de Salud Carlos III (ISCIII)/FEDER) [PI19/01090]
dc.relation.projectIDOMI-COVI-VAC (European Regional Development Fund) [PI22/00406]
dc.relation.projectIDOMI-COVI-VAC (Grupos de Referencia Competitiva) [IIN607A2021/05]
dc.relation.projectIDOMI-COVI-VAC (Axencia Galega de Innovacion (GAIN-Xunta de Galicia
dc.relation.projectIDSpain) [IN845D 2020/23]
dc.relation.projectIDNIRSE-GAL Project grant 2023 from Sanofi Pasteur
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.es.2023.28.49.2300606
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordDXSP
dc.subject.keywordDXSP
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number28


Ficheros en el ítem

Descargar/
Nombre:
977.pdf
Tamaño:
96.44Kb
Formato:
PDF
Descripción:
Martinón-Torres F, Mirás-Carballal S, Durán-Parrondo C. Early lessons from the ...

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International (CC BY 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)